Every person I've spoken to about taking these medications has emphasized that, whether or not they had diagnosed health conditions, they simply wanted to feel better and did, after taking a GLP-1
Published preclinical studies describe cytoprotection-associated, pro-migratory, angiogenesis-associated, endothelial, and tissue-repair-related endpoints observed in defined laboratory model systems
Studies show that most patients stop using GLP-1 medications within two years due to financial challenges, side effects or lack of adequate medical guidance
There is no published clinical data supporting the efficacy of oral semaglutide drops, and no oral form of tirzepatide has been studied or approved in any capacity
Willow works with some insurance plans, while providers like Klarity Health accept a broader range of insurance options and can help determine your coverage before starting treatment